EP Patent

EP0327295A2 — Tetracycline dosage form

Assigned to Mayne Pharma International Pty Ltd · Expires 1989-08-09 · 37y expired

What this patent protects

A pharmaceutical composition including a core element with at least one active ingredient with at least one tetracycline antibiotic, and a core coating for the core element which is partially soluble at an acidic pH. In use, a dissolution profile is generated for the pellet compo…

USPTO Abstract

A pharmaceutical composition including a core element with at least one active ingredient with at least one tetracycline antibiotic, and a core coating for the core element which is partially soluble at an acidic pH. In use, a dissolution profile is generated for the pellet composition which is equal to or greater than the minimum dissolution profile required to provide bioequivalence with a capsule or tablet containing an equal amount of the active ingredient in an uncoated form.

Drugs covered by this patent

Patent Metadata

Patent number
EP0327295A2
Jurisdiction
EP
Classification
—
Expires
1989-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Mayne Pharma International Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.